Bell's palsy and SARS-CoV-2 vaccines
- 24 February 2021
- journal article
- editorial
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 21 (4), 450-452
- https://doi.org/10.1016/s1473-3099(21)00076-1
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases
This publication has 10 references indexed in Scilit:
- Ensuring vaccine safetyScience, 2020
- Do Vaccines Have a Role as a Cause of Autoimmune Neurological Syndromes?Frontiers in Public Health, 2020
- Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccineVaccine, 2017
- Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-OldsPEDIATRICS, 2017
- Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitisF1000Research, 2013
- The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysisVaccine, 2012
- Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, SwedenBMJ, 2011
- A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001,Pharmacoepidemiology and Drug Safety, 2004
- LETTER: Bell's Palsy: A Rare Complication of Interferon Therapy for Hepatitis CDigestive Diseases and Sciences, 2004
- Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in SwitzerlandThe New England Journal of Medicine, 2004